InsidersTradesSigma
東和薬品株式会社: management transactions · Japan · EDINET (Japan FSA)
EDINET:company-5e991dJP·EDINET (Japan FSA)Mcap 190.3Bn€Healthcare
Browse the full directors' dealings record of 東和薬品株式会社, a listed equity based in Japan. Shares are quoted on JP JP, under the authority of EDINET (Japan FSA). Operating in the Healthcare sector, 東和薬品株式会社 has published 1 reports. Market capitalisation: €190.3bn. The latest transaction was disclosed on 6 June 2023 — Holding update. Among the most active insiders: LSV Asset Management. The full history is free.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
3865.00 €
Analyst consensus
6 analystsBuy
4400.00 €Target 4900.00 €(+27%)5500.00 €
Income statement
Revenue259.59 Bn€
Gross profit94.73 Bn€36% margin
Net income18.99 Bn€1.9% margin
Valuation
PER (trailing)36.2x
P/Book1.1x
Balance sheet & cash
Market cap190.27 Bn€
Total debt230.98 Bn€
Free Cash Flow−7.82 Bn€
Debt / Equity129%
Profitability & ownership
ROE3.0%
ROA3.1%
% insiders48.2%
% institutions20.3%
Last declaration on 6 June 2023
Declarations1 total
Executives●Holding update21EDINET
€35m100.0% of flow
ShareXTKS
EDINET:S100QTZZ·
1 of 1 declaration